New “Show Me How” Video Section

How can I validate a nomogram? Show me the model.

therapies approved; capecitabine plus lapatinib is an option [4, 5]. With regard to trastuzumab, its activity in the CNS has always been considered very poor, because of difficulty of penetration and insufficient activation of antibody-dependent cellular cytotoxicity (ADCC) in the brain. We report the case of a 63-year-old woman with HER2-positive brain metastases who experienced long-term remi...

Show me the data

The integrity of data, and transparency about their acquisition, are vital to science. The impact factor data that are gathered and sold by Thomson Scientifi c (formerly the Institute of Scientifi c Information, or ISI) have a strong infl uence on the scientifi c community, affecting decisions on where to publish, whom to promote or hire (1), the success of grant applications (2), and even sala...

Show me the money.

Show me the money: the new death investigation system.

Biotechs: Show Me the Money

Money makes the biotech world go around. However, quicker circulation of that cash is driving both trends in new investment in start-ups and the approach of investors to exits. Increasingly, to get funded, new companies need to demonstrate a fast track approach that will allow the company to hit key milestone events swiftly, and those milestones may well be revenue generation events or even pro...